Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Product revenues $ 1,628,435 $ 1,580,826 $ 5,443,287 $ 4,013,531
Service and other revenues 88,635 35,507 256,860 100,818
Total revenues 1,717,070 1,616,333 5,700,147 4,114,349
Cost of product revenues 688,847 748,305 2,239,808 1,965,839
Research and development costs 589,716 691,330 2,231,616 2,098,465
Selling, general, and administrative expenses 1,765,830 1,886,220 5,731,961 5,748,524
Operating loss (1,327,323) (1,709,522) (4,503,238) (5,698,479)
Other income (expense):        
Loss from debt restructuring (933,134) (811,909)
Gain from change in fair value of derivative liabilities 109,803 324,035 48,064 748,080
Other income (expense), net 3,363 (4,877) 6,774 209,504
Interest expense, net (211,362) (239,733) (637,270) (836,208)
Net loss $ (1,425,519) $ (2,563,231) $ (5,085,670) $ (6,389,012)
Net loss per share attributable to common stockholders:        
Basic and diluted (in dollars per share) $ (0.14) $ (0.92) $ (0.75) $ (2.59)
Weighted average shares outstanding:        
Basic and diluted (in shares) 10,339,210 2,779,803 6,783,605 2,467,437